Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Widimsky

Showing results (101-110 of 232) with videos related to

Pageof 24
Sort By:
Journal of Cardiothoracic Surgery|September 2, 2020
A contemporary approach to a young female patient with Loeys-Dietz syndrome and an uncomplicated type B aortic dissection: a case reportPetko Prodanov, Hana Linkova, Robert Petr, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2020
Long-term outcomes of thrombectomy for acute ischaemic stroke by occluded artery and stroke aetiology: a PRAGUE-16 substudyJana Vavrova, Boris Koznar, Tomas Peisker, et al.
Circulation|November 24, 2004
One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trialPetr Widimsky, Zbynek Straka, Petr Stros, et al.
Journal of Cardiovascular Electrophysiology|August 17, 2021
The effect of left atrial appendage closure on heart failure biomarkers: A PRAGUE-17 trial subanalysisDalibor Herman, Pavel Osmancik, Petr Neuzil, et al.
JAMA|May 7, 2009
Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary interventionRajendra H Mehta, Aijing Z Starr, Renato D Lopes, et al.
European Heart Journal|January 9, 2007
Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularizationMartin Penicka, Petr Tousek, Bernard De Bruyne, et al.
Plos One|May 26, 2017
Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 studyMartina Ondrakova, Zuzana Motovska, Petr Waldauf, et al.
Journal of the American College of Cardiology|May 24, 2008
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysisElliott M Antman, Stephen D Wiviott, Sabina A Murphy, et al.
American Heart Journal|April 9, 2011
A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST studyGilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Journal of the American College of Cardiology|March 19, 2013
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51)Jessica L Mega, Eugene Braunwald, Sabina A Murphy, et al.
Pageof 24

Showing results (101-110 of 232) with videos related to

Sort By:
Pageof 24
Journal of Cardiothoracic Surgery|September 2, 2020
A contemporary approach to a young female patient with Loeys-Dietz syndrome and an uncomplicated type B aortic dissection: a case reportPetko Prodanov, Hana Linkova, Robert Petr, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 19, 2020
Long-term outcomes of thrombectomy for acute ischaemic stroke by occluded artery and stroke aetiology: a PRAGUE-16 substudyJana Vavrova, Boris Koznar, Tomas Peisker, et al.
Circulation|November 24, 2004
One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trialPetr Widimsky, Zbynek Straka, Petr Stros, et al.
Journal of Cardiovascular Electrophysiology|August 17, 2021
The effect of left atrial appendage closure on heart failure biomarkers: A PRAGUE-17 trial subanalysisDalibor Herman, Pavel Osmancik, Petr Neuzil, et al.
JAMA|May 7, 2009
Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary interventionRajendra H Mehta, Aijing Z Starr, Renato D Lopes, et al.
European Heart Journal|January 9, 2007
Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularizationMartin Penicka, Petr Tousek, Bernard De Bruyne, et al.
Plos One|May 26, 2017
Antithrombotic therapy of patients with atrial fibrillation discharged after major non-cardiac surgery. 1-year follow-up. Sub-analysis of PRAGUE 14 studyMartina Ondrakova, Zuzana Motovska, Petr Waldauf, et al.
Journal of the American College of Cardiology|May 24, 2008
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysisElliott M Antman, Stephen D Wiviott, Sabina A Murphy, et al.
American Heart Journal|April 9, 2011
A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST studyGilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Journal of the American College of Cardiology|March 19, 2013
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51)Jessica L Mega, Eugene Braunwald, Sabina A Murphy, et al.
Pageof 24